Discover the latest advances in stem cell therapy

Learn about the basic biology and potential clinical applications of cellular therapies. This symposium will feature presentations by some of the nation’s most renowned scientists and physicians leading the field of cell-based therapy research and development.

ViaCell’s Research Presentations: Orange County Convention Center, Hall C

· See how ViaCell’s patented cellular expansion technology, Selective AmplificationÔ, shows the ability to remove the potentially injurious mature T-cell population while maintaining immature T-cells capable of further differentiation. This may lead to a reduced incidence of Graft versus Host Disease while allowing an increased rate of engraftment and a beneficial contribution to Graft versus Leukemia effect. Presentation: # 2750, Monday, December 10, 5:15-6:30 PM

· Learn about ViaCell’s studies demonstrating that umbilical cord blood stem cell populations expanded and purified through ViaCell’s Selective AmplificationÔ technology show engraftment ability in NOD/Scid mice, as evidenced by the presence of human DNA in their bone marrow. Presentation: # 2765, Monday, December 10, 5:15-6:30 PM

· Hear ViaCell researchers discuss the discovery of a protein that appears to play an important role in regulating the expansion and engraftment potential of human hematopoietic stem cell populations. Presentations: #297 and #320, Saturday, December 8, 6:00-7:15 PM

Meet with a leading ViaCell researcher to learn about advancements in ViaCell’s research and development in the area of cellular therapy

For more information or to schedule an interview, contact: John Capodanno of Noonan/Russo Communications, Inc., 212-696-4455 ext. 246
[email protected]
or Debbie Donihoo of ViaCell, Inc., 469-964-6789 [email protected]

For more information on ViaCell, Inc., please visit www.viacellinc.com